Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 3, 2003, Pages 400-405

  Ahmed, Mohamed N ^a   Suliman, Hagir B ^a   Folz, Rodney J ^a   Nozik Grayck, Eva ^a   Golson, Maria L ^a   Mason, S Nicholas ^a   Auten, Richard L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bronchopulmonary dysplasia; Hyperoxia; Newborn infant; Superoxide dismutase; Transgenic mice

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HYPEROXIA; LUNG DEVELOPMENT; LUNG DYSPLASIA; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CHRONIC DISEASE; EXTRACELLULAR SPACE; HYPEROXIA; LUNG; MICE; MICE, TRANSGENIC; SUPEROXIDE DISMUTASE;

EID: 0037320049     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200202-108OC     Document Type: Article

References (32)

1. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
2. Jobe A. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-643.
3. Randell SH, Mercer RR, Young SL. Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats. Am J Pathol 1990;136:1259-1266.
4. Massaro DJ. Massaro GD. Regulation of pulmonary alveoli formation. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 479-492.
5. Lorant DE, Albertine K, Bohnsack JF. Chronic lung disease of early infancy: role of neutrophils. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 793-812.
6. Coalson J. Pathology of chronic lung disease of early infancy. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 85-124.
7. Frank L, Sosenko IR. Oxidants and antioxidants: what role do they play in chronic lung disease? In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 257-284.
8. Rogers S, Witz G, Anwar M, Hiatt M, Hegyi T. Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch Pediatr Adolesc Med 2000;154:544-548.
9. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL. Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001;50:29-33.
10. Singh SK, Tandon A, Kumari S, Ravi RN, Ray GN, Batra S. Changes in anti-oxidant enzymes and lipid peroxidation in hyaline membrane disease. Indian J Pediatr 1998;65:609-614.
11. Berger TM, Frei B, Rifai N, Avery ME, Suh J, Yoder BA, Coalson JJ. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 1998;43:719-726.
12. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, et al. Vitamin A supplementation for extremely-low-birth-weight infants: National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962-1968.
13. Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, et al. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24-30.
14. Berrington WR, Tarpey MM, Freeman BA, Pitt BR. Site- and mechanism-targeted interventions for tissue free radical injury. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 883-909.
15. Welty SE, Smith CV. Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia. Nutr Rev 2001;59:10-17.
16. Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, Whitsett JA. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 1992;267:23937-23941.
17. Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999;103:1055-1066.
18. Carlsson LM, Johnsson J, Edlung T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995;92:6246-6268.
19. Randell SH, Young SL. Unique features of the immature lung. In: Bland RD, Coalson J, editors. Chronic lung disease in early infancy, lung biology in health and disease. New York: Marcel Dekker; 2000. p. 377-403.
20. Korfhagen TR, Glasser SW, Wert SE, Bruno MD, Daugherty CC, McNeish JD, Stock JL, Potter SS, Whitsett JA. Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc Natl Acad Sci USA 1990;87:6122-6126.
21. Deng H, Mason SN, Auten RL Jr. Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. Am J Respir Crit Care Med 2000;162:2316-2323.
22. 51Cr-labeled cells and myeloperoxidase. Inflammation 1983;7:247-255.
23. Aderibigbe AO, Thomas RF, Mercer RR, Auten R. Brief exposure to 95% oxygen alters surfactant protein D and mRNA in adult rat alveolar and bronchiolar epithelium. Am J Respir Cell Mol Biol 1999;20:219-227.
24. Paroni R, De Vecchi E, Cighetti G, Arcelloni C, Fermo I, Grossi A, Bonini P. HPLC with o-phthalaldehyde precolumn derivatization to measure total, oxidized, and protein-bound glutathione in blood, plasma, and tissue. Clin Chem 1995;41:448-454.
25. Ahmed MN, Grayck EN, Suliman H, Mason SN, Auten RL. Overexpression of extracellular superoxide dismutase (EC-SOD) protects against hyperoxia-induced airway inflammation in transgenic newborn mice [abstract]. Pediatr Res 2001;49:300a.
26. Auten RL Jr, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH. Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol Lung Cell Mol Physiol 2001;281:L336-L344.
27. White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991;87:2162-2168.
28. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989;139:370-372.
29. Hoidal JR, Hoidal MK. Proteolytic enzymes and their inhibitors in lung health and disease. In: Lenfant C, editor. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000. p. 859-882.
30. Jankov RP, Negus A, Tanswell AK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 2001;50:681-687.
31. Minoo P, Segura L, Coalson JJ, King RJ, DeLemos RA. Alterations in surfactant protein gene expression associated with premature birth and exposure to hyperoxia. Am J Physiol 1991;261:L386-L392.
32. 2 exposure effects on surfactant protein and mRNA in rat alveolar and bronchiolar epithelium. Am J Physiol 1999;276:L999-L1009.